THE INDIAN PHARMACIST Official Circular Pharmacy Logo THE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
DIETARY SUPPLEMENT & NUTRACEUTICAL PROFILE CODE: [SUP-15] ID: TIP-MED-000639

Glucosamine Sulfate + Chondroitin Sulfate

Active Ingredient / Scientific Identity: Glucosamine Sulfate Potassium Chloride + Chondroitin Sulfate • Class: Clinical Nutrition & Nutraceutical Science • Amino Monosaccharide & Sulfated Glycosaminoglycan Proteoglycan Precursors

⚖️ Compare 579 Drugs
THE INDIAN PHARMACIST — Educational Reference Sheet
Profile: Glucosamine Sulfate + Chondroitin Sulfate ([SUP-15] | ID: TIP-MED-000639) • Last Reviewed: 2026-11-10
Source URL: https://theindianpharmacist.com/medicine/sup-15-glucosamine-sulfate-potassium-chloride-chondroitin-sulfate/
Generic / Entity NameGlucosamine Sulfate + Chondroitin Sulfate ([SUP-15])
Verified Indian Brands / RefFSSAI Licensed Health Supplement / Nutraceutical Formulations (RDA Compliant)
Pharmacological ClassClinical Nutrition & Nutraceutical Science • Amino Monosaccharide & Sulfated Glycosaminogl
Available Dosage FormsStandard Supplemental Regimen: Glucosamine Sulfate Crystalline 1,500 mg once daily (or 500 mg TID) +/- Chondro
Regulatory ClassificationFSSAI Nutraceutical Regulation, 2022 (Mandatory label declaration if derived from cru
Key Warning & Review DateMild epigastric discomfort, heartburn, diarrhoea, or constipation; shellfish-derived glucosamine contains tropomyosin trace r
Reviewed: 2026-11-10
Safety Matrix:⚖️ Regulatory Framework: FSSAI Nutraceutical Regulation, 2022 (Mandatory labe✔️ Standard Clinical Dispensing Precautions

1. Clinical & Scientific Overview

Glucosamine Sulfate + Chondroitin Sulfate (TIP-MED-000639, Reference Code [SUP-15]) is classified under Dietary Supplements & Nutraceuticals (FSSAI / ICMR-NIN) as a Clinical Nutrition & Nutraceutical Science • Amino Monosaccharide & Sulfated Glycosaminoglycan Proteoglycan Precursors. Within the Indian regulatory and compendial framework, it is governed under FSSAI Nutraceutical Regulation, 2022 (Mandatory label declaration if derived from crustacean shellfish allergen)..

Verified Indian Market Examples / Compendial Status:
FSSAI Licensed Health Supplement / Nutraceutical Formulations (RDA Compliant)
Nutritional & Regulatory Reference: Standard Supplemental Regimen: Glucosamine Sulfate Crystalline 1,500 mg once daily (or 500 mg TID) +/- Chondroitin Sulfate 800–1,200 mg/day (Clinical note: Prescription-grade crystalline glucosamine sulfate shows modest symptomatic benefit in knee OA in European ESCEO guidelines, whereas glucosamine hydrochloride and generic combinations failed to beat placebo in the NIH GAIT trial and are not recommended as disease-modifying in ACR guidelines). (FSSAI Nutraceutical Regulation, 2022 (Mandatory label declaration if derived from crustacean shellfish allergen).).
Dosage Forms & Available Strengths:
Standard Supplemental Regimen: Glucosamine Sulfate Crystalline 1,500 mg once daily (or 500 mg TID) +/- Chondroitin Sulfate 800–1,200 mg/day (Clinical note: Prescription-grade crystalline glucosamine sulfate shows modest symptomatic benefit in knee OA in European ESCEO guidelines, whereas glucosamine hydrochloride and generic combinations failed to beat placebo in the NIH GAIT trial and are not recommended as disease-modifying in ACR guidelines).
Routes: Oral Nutritional Supplementation

Clinical Nutrition, ICMR-NIN RDA & FSSAI Nutraceutical Profile

Nutrient / Nutraceutical Identity:
Glucosamine Sulfate Potassium Chloride + Chondroitin Sulfate
Category:
Amino Monosaccharide & Sulfated Glycosaminoglycan Proteoglycan Precursors
Natural Dietary Sources (Indian Context):
Exoskeleton of marine crustaceans (shrimp/crab shells — Vegetarian Aspergillus niger fermented glucosamine available for shellfish-allergic or vegetarian users) and bovine/shark cartilage

ICMR-NIN 2024 Recommended Dietary Allowance (RDA) & Tolerable Upper Intake Limit (UL): Standard Supplemental Regimen: Glucosamine Sulfate Crystalline 1,500 mg once daily (or 500 mg TID) +/- Chondroitin Sulfate 800–1,200 mg/day (Clinical note: Prescription-grade crystalline glucosamine sulfate shows modest symptomatic benefit in knee OA in European ESCEO guidelines, whereas glucosamine hydrochloride and generic combinations failed to beat placebo in the NIH GAIT trial and are not recommended as disease-modifying in ACR guidelines).

Deficiency Clinical Syndromes vs Chronic Excess / Hypervitaminosis Risks: Mild epigastric discomfort, heartburn, diarrhoea, or constipation; shellfish-derived glucosamine contains tropomyosin trace risks for patients with severe IgE-mediated crustacean anaphylaxis (use fermented vegetarian glucosamine instead).

Drug–Nutrient Chelation & Timing Interactions: CRITICAL WARFARIN WARNING: Glucosamine (with or without chondroitin) has been reported in pharmacovigilance registries to potentiate Warfarin, causing supratherapeutic INR rises and haemorrhage — monitor INR closely or avoid in warfarin users! Check sodium/potassium load of crystalline salts in heart failure or CKD.

FSSAI Health Supplement vs Therapeutic Drug Distinction: FSSAI Nutraceutical Regulation, 2022 (Mandatory label declaration if derived from crustacean shellfish allergen).

3. Mechanism of Action & Pharmacodynamics

Glucosamine is a substrate for hyaluronic acid and keratan/chondroitin sulfate glycosaminoglycan chains in articular cartilage aggrecan, and weakly inhibits IL-1beta-induced NF-kappa-B activation and matrix metalloproteinases (MMP-3, MMP-13) in chondrocytes.

4. Therapeutic Indications & Evidence-Supported Uses

  • Physiological & Biochemical Role: Glucosamine is a substrate for hyaluronic acid and keratan/chondroitin sulfate glycosaminoglycan chains in articular cartilage aggrecan, and weakly inhibits IL-1beta-induced NF-kappa-B activation and matrix metalloproteinases (MMP-3, MMP-13) in chondrocytes.
  • Dietary Sources: Exoskeleton of marine crustaceans (shrimp/crab shells — Vegetarian Aspergillus niger fermented glucosamine available for shellfish-allergic or vegetarian users) and bovine/shark cartilage
  • ICMR-NIN RDA & Upper Limits: Standard Supplemental Regimen: Glucosamine Sulfate Crystalline 1,500 mg once daily (or 500 mg TID) +/- Chondroitin Sulfate 800–1,200 mg/day (Clinical note: Prescription-grade crystalline glucosamine sulfate shows modest symptomatic benefit in knee OA in European ESCEO guidelines, whereas glucosamine hydrochloride and generic combinations failed to beat placebo in the NIH GAIT trial and are not recommended as disease-modifying in ACR guidelines).

🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.

5. Educational Dosage Context, Formulations & Administration

Educational Dosing & Regimen Summary: Standard Supplemental Regimen: Glucosamine Sulfate Crystalline 1,500 mg once daily (or 500 mg TID) +/- Chondroitin Sulfate 800–1,200 mg/day (Clinical note: Prescription-grade crystalline glucosamine sulfate shows modest symptomatic benefit in knee OA in European ESCEO guidelines, whereas glucosamine hydrochloride and generic combinations failed to beat placebo in the NIH GAIT trial and are not recommended as disease-modifying in ACR guidelines).

Administration & Meal Timing: CRITICAL WARFARIN WARNING: Glucosamine (with or without chondroitin) has been reported in pharmacovigilance registries to potentiate Warfarin, causing supratherapeutic INR rises and haemorrhage — monitor INR closely or avoid in warfarin users! Check sodium/potassium load of crystalline salts in heart failure or CKD.

6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment

Absorption & Disposition:
Salt-form and meal-timing dependent gastrointestinal absorption; see bioavailability and drug-nutrient chelation notes (CRITICAL WARFARIN WARNING: Glucosamine (with or without chondroitin) has been reported in pharmacovigilance registries to potentiate Warfarin, causing supratherapeutic INR rises and haemorrhage — monitor INR closely or avoid in warfarin users! Check sodium/potassium load of crystalline salts in heart failure or CKD.).
Metabolism & Biotransformation:
Incorporated into cellular coenzyme pools, metalloproteins, or membrane phospholipids.
Elimination & Renal Adjustment:
Caution with magnesium, potassium, calcium, vitamin D, and high-dose vitamin C/collagen (oxalate) in Chronic Kidney Disease.
Hepatic Impairment Considerations:
Caution with fat-soluble vitamins and concentrated lipophilic extracts in hepatobiliary disease.

7. Contraindications, Precautions & High-Risk Warnings

Contraindications & Red-Flag Precautions:
  • Supratherapeutic megadosing above the ICMR-NIN Tolerable Upper Intake Level (UL) without medical indication
  • Mild epigastric discomfort, heartburn, diarrhoea, or constipation; shellfish-derived glucosamine contains tropomyosin trace risks for patients with severe IgE-mediated crustacean anaphylaxis (use fermented vegetarian glucosamine instead).

Key Clinical Precautions: Mild epigastric discomfort, heartburn, diarrhoea, or constipation; shellfish-derived glucosamine contains tropomyosin trace risks for patients with severe IgE-mediated crustacean anaphylaxis (use fermented vegetarian glucosamine instead).

8. Adverse Effects Profile

Common & Mechanism-Related Adverse Effects:
  • Mild epigastric discomfort, heartburn, diarrhoea, or constipation; shellfish-derived glucosamine contains tropomyosin trace risks for patients with severe IgE-mediated crustacean anaphylaxis (use fermented vegetarian glucosamine instead).
Serious / Dose-Limiting Adverse Effects:
  • Mild epigastric discomfort, heartburn, diarrhoea, or constipation; shellfish-derived glucosamine contains tropomyosin trace risks for patients with severe IgE-mediated crustacean anaphylaxis (use fermented vegetarian glucosamine instead).

9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions

  • CRITICAL WARFARIN WARNING: Glucosamine (with or without chondroitin) has been reported in pharmacovigilance registries to potentiate Warfarin, causing supratherapeutic INR rises and haemorrhage — monitor INR closely or avoid in warfarin users! Check sodium/potassium load of crystalline salts in heart failure or CKD.

10. Clinical Monitoring, Patient Counselling & Storage

Clinical & Laboratory Monitoring: Verify whether the patient requires physiological nutritional maintenance (<=1 RDA under FSSAI) or high-dose therapeutic deficiency correction (Schedule H/medical supervision), and check for multi-supplement stacking.

Pharmacist Patient Counselling Points:

  • CRITICAL WARFARIN WARNING: Glucosamine (with or without chondroitin) has been reported in pharmacovigilance registries to potentiate Warfarin, causing supratherapeutic INR rises and haemorrhage — monitor INR closely or avoid in warfarin users! Check sodium/potassium load of crystalline salts in heart failure or CKD.
  • Check all multivitamin and wellness labels to avoid accidentally doubling up on fat-soluble vitamins (A, D, E, K), iron, or zinc.
  • Health supplements support normal physiological nutrition and are NOT intended to diagnose, treat, cure, or prevent disease under Section 22 of the FSS Act, 2006.

Storage, Stability & Dispensing Safeguards: Store in a cool, dry place below 25°C away from moisture and direct sunlight; verify FSSAI License Number and Veg/Non-Veg symbol on packaging.

11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)

THE 12-STEP ORAL DRUG JOURNEY THROUGH THE HUMAN BODY (LADME) Note: IV bolus enters Step 6 directly (F = 100%); Sublingual & Transdermal routes bypass Step 4–5 Portal First-Pass Metabolism 1. Oral Administration • Tablet / Capsule swallowed • Gastric emptying to duodenum pH 1.5–3.5 (Stomach) 2. Disintegration & Dissolution • Tablet breaks into granules • API dissolves in GI fluid Noyes-Whitney Dissolution Rate 3. GI Epithelial Absorption • Crosses intestinal villi • Passive / Active / P-gp efflux Small Intestine (Large Surface Area) 4. Portal Circulation • Mesenteric veins → Portal vein • Delivers blood to liver sinusoids Pre-systemic Venous Conduit 5. First-Pass Metabolism • Gut & hepatic CYP450 extraction • High: GTN, Propranolol, Morphine Determines Bioavailability (F = f_a × (1-E_H)) 6. Systemic Circulation • Hepatic vein → IVC → Heart • Unbound vs Albumin-bound drug Only FREE drug is active 7–8. Tissue Distribution (Vd) • Capillary permeation to organs • Blood-Brain & Placental barriers Vd = Dose / C_0 (L or L/kg) 9. Target Site of Action • Receptors (GPCR, Ion channel) • Enzymes & Carrier Transporters Pharmacodynamic Effect (E_max, EC50) 10. Hepatic Biotransformation • Phase I (CYP450 Oxidation/Hydrolysis) • Phase II (Glucuronidation/Sulfation) Converts lipophilic drug → hydrophilic metabolite 11. Renal & Biliary Elimination • Nephron: Filtration + Secretion − Reabsorption • Biliary excretion & Enterohepatic recycling Total Clearance CL_tot = CL_renal + CL_hepatic 12. Excretion from the Body • Urine (Primary polar metabolite route) • Bile/Faeces, Expired Air, Sweat, Milk Elimination Half-Life t1/2 = (0.693 × Vd) / CL
svg-v339-01-adme-12-step-journey — 8.1 Complete 12-Step Journey of an Orally Administered Drug (ADME): Figure 8.1: The 12-step physiological journey of a typical orally administered solid dosage form through Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME). Note: Parenteral (IV), sublingual, and inhalational routes bypass gastrointestinal absorption and/or hepatic first-pass metabolism.

12. Authoritative References, Regulatory Sources & Editorial Disclaimer

Primary Compendial & Guideline Reference: ICMR-NIN (National Institute of Nutrition) Nutrient Requirements and Recommended Dietary Allowances (RDA) for Indians (2020/2024); FSSAI (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2022.

Official Verification Portals: ICMR-National Institute of Nutrition (NIN) — Dietary Guidelines & Nutrient Requirements for Indians • FSSAI — Food Safety and Standards (Health Supplements and Nutraceuticals) Regulations

Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT

Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.

← Back to All 644 Reference Profiles 📖 Explore 40 Knowledge Hub Articles → ✉️ Report Errata / Feedback
Educational Reference Notice: This printout from THE INDIAN PHARMACIST (https://theindianpharmacist.com/medicine/sup-15-glucosamine-sulfate-potassium-chloride-chondroitin-sulfate/, Last Reviewed: 2026-11-10) is an educational reference sheet for students and healthcare learners. It is NOT an official prescribing guideline or patient-specific treatment order.